Charles Schwab Investment Management Inc Matinas Bio Pharma Holdings, Inc. Transaction History

Charles Schwab Investment Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	BUY	$0.96 - $1.74 $41,559 - $75,326	43,291 Added 123.35%	78,387 $83,000
Q1 2019 May 14, 2019	BUY	$0.6 - $1.41 $21,057 - $49,485	35,096 New	35,096 $39,000
Q2 2018 Aug 08, 2018	SELL	$0.42 - $0.74 $37,590 - $66,230	-89,500 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$1.19 - $1.43 $106,505 - $127,985	89,500	89,500 $119,000

2.74M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.